{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:07:03Z","timestamp":1779210423402,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NextGenerationEU, European Union"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15950-2","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:37:16Z","timestamp":1775457436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for glioblastoma: study protocol for a phase I multicenter clinical trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Nadia","family":"Di Muzio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Torrisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Barzaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Pocaterra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Folchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micol","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Bailo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara Lucrezia","family":"Deantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Snider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Ruffino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Di Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Mercogliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Mondino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"15950_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12","volume":"134","author":"HG Wirsching","year":"2016","unstructured":"Wirsching HG, Galanis E, Weller M, Glioblastoma. Handb Clin Neurol. 2016;134:381\u201397. https:\/\/doi.org\/10.1016\/B978-0-12-802997-8.00023-2, indexed in Pubmed: 26948367.","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"15950_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"S Roger","year":"2005","unstructured":"Roger S, Mason Warren P, van den Bent Martin J, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"10","key":"15950_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"issue":"35","key":"15950_CR4","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1200\/JCO.2015.62.660","volume":"33","author":"W Roa","year":"2015","unstructured":"Roa W, Kepka L, Kumar N, et al. International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and\/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme. J Clin Oncol. 2015;33(35):4145\u201350. https:\/\/doi.org\/10.1200\/JCO.2015.62.660.","journal-title":"J Clin Oncol"},{"key":"15950_CR5","doi-asserted-by":"publisher","first-page":"110696","DOI":"10.1016\/j.radonc.2024.110696","volume":"204","author":"N Andratschke","year":"2025","unstructured":"Andratschke N, Heusel A, Albert NL, et al. ESTRO\/EANO recommendation on reirradiation of glioblastoma. Radiother Oncol. 2025;204:110696. https:\/\/doi.org\/10.1016\/j.radonc.2024.110696.","journal-title":"Radiother Oncol"},{"key":"15950_CR6","doi-asserted-by":"publisher","first-page":"20200042","DOI":"10.1259\/bjr.20200042)","volume":"93","author":"S Demaria","year":"2020","unstructured":"Demaria S, Formenti SC. The abscopal effect 67 years later: from a side story to center stage. Br J Radiol. 2020;93:20200042. https:\/\/doi.org\/10.1259\/bjr.20200042).","journal-title":"Br J Radiol"},{"key":"15950_CR7","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/j.prro.2023.01.008","volume":"13","author":"MG Mendoza","year":"2023","unstructured":"Mendoza MG, Azoulay M, Chang SD, et al. Patterns of progression in patients with newly diagnosed glioblastoma treated with 5-mm margins in a phase \u00bd trial of 5 -fraction stereotactic radiosurgery with concurrent and adjuvant temozolomide. Pract Rad Oncol. 2023;13:e239\u201345.","journal-title":"Pract Rad Oncol"},{"key":"15950_CR8","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.3390\/cancers15235650","volume":"15","author":"C Jiang","year":"2023","unstructured":"Jiang C, Mogilevsky C, Belal Z, et al. Hypofractionation in glioblastoma: an overview of palliative, definitive and exploratory uses. Cancers. 2023;15:5650.","journal-title":"Cancers"},{"key":"15950_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1158\/1078-0432.CCR-05-1762","volume":"12","author":"GA Omura","year":"2006","unstructured":"Omura GA. Phase 1 Dose-finding trials and Fibonacci. Clin Cancer Res. 2006;12:321. 10.1158\/1078\u2009\u2013\u20090432.CCR-05-1762.","journal-title":"Clin Cancer Res"},{"key":"15950_CR10","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1200\/JCO.2003.99.058","volume":"21","author":"GA Omura","year":"2003","unstructured":"Omura GA. Modified Fibonacci search. J Clin Oncol. 2003;21:3177\u201379. https:\/\/doi.org\/10.1200\/JCO.2003.99.058.","journal-title":"J Clin Oncol"},{"key":"15950_CR11","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017."},{"key":"15950_CR12","doi-asserted-by":"publisher","first-page":"109663","DOI":"10.1016\/j.radonc.2023.109663","volume":"184","author":"M Niyazi","year":"2023","unstructured":"Niyazi M, Andratschke N, Bendszus M, et al. ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma. Radiother Oncol. 2023;184:109663. https:\/\/doi.org\/10.1016\/j.radonc.2023.109663.","journal-title":"Radiother Oncol"},{"issue":"1","key":"15950_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11060-019-03152-9","volume":"143","author":"TJ Kruser","year":"2019","unstructured":"Kruser TJ, Bosch WR, Badiyan SN, et al. NRG Brain Tumor Specialists Consensus Guidelines for Glioblastoma Contouring. J Neurooncol. 2019;143(1):157\u201366. https:\/\/doi.org\/10.1007\/s11060-019-03152-9.","journal-title":"J Neurooncol"},{"issue":"1","key":"15950_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","volume":"110","author":"MT Milano","year":"2020","unstructured":"Milano MT, Grimm J, Niemierko A, et al. Single and multi-fraction stereotactic radiosurgery dose\/volume tolerances of the brain. Int J Radiat Oncol Bio Phys. 2020;110(1):68\u201386.","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"15950_CR15","unstructured":"U.S.Food and Drug Administration. 510(k) Premarket Notification: K102650. AccessData FDA. 2010. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/k102650.pdf."},{"issue":"44","key":"15950_CR16","doi-asserted-by":"publisher","first-page":"e40365","DOI":"10.1097\/MD.0000000000040365","volume":"103","author":"W You","year":"2024","unstructured":"You W, Chen C, Chu H, et al. Quantifying thermoplastic mask quality for precision radiotherapy in head and neck cancer: A 3D stress test and 6D-axis error analysis. Medicine. 2024;103(44):e40365.","journal-title":"Medicine"},{"key":"15950_CR17","doi-asserted-by":"publisher","unstructured":"ChenA et al. Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma International Journal of Radiation Oncology, Biology, Physics. 2024;119:1122\u201332. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.01.013.","DOI":"10.1016\/j.ijrobp.2024.01.013"},{"key":"15950_CR18","doi-asserted-by":"publisher","unstructured":"AzoulayM, et al. A phase I\/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma. Neuro Oncol Pract. 2020;22(8):1182\u20139. https:\/\/doi.org\/10.1093\/neuonc\/noaa019.","DOI":"10.1093\/neuonc\/noaa019"},{"key":"15950_CR19","doi-asserted-by":"publisher","unstructured":"Yilmaz MT et al. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: multicenter outcomes review. J Neurooncol. 2024;167(2):295\u2013303. https:\/\/doi.org\/10.1007\/s11060-024-04607-4.","DOI":"10.1007\/s11060-024-04607-4"},{"key":"15950_CR20","doi-asserted-by":"crossref","unstructured":"Kim MS et al. Re-irradiation for recurrent glioblastoma: contribution to prognosis and outcomes. Front Oncol. 2020;8(1):29\u201335.; (PMC7221471).","DOI":"10.14791\/btrt.2020.8.e10"},{"key":"15950_CR21","unstructured":"Comparative outcomes of standard RT and 5-fraction adaptive stereotactic RT (Adv Radiat Oncol \/ Advances in Radiation Oncology). 2025. recent comparative analysis."},{"key":"15950_CR22","unstructured":"Cureus. Impact of Reirradiation Utilizing Fractionated Stereotactic Radiotherapy for Recurrent Glioblastoma. 2023."},{"issue":"16","key":"15950_CR23","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-11-1061","volume":"17","author":"SA Grossman","year":"2011","unstructured":"Grossman SA, Ye X, Lesser G, Sloan A, Carraway H, Desideri S, et al. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res. 2011;17(16):5473\u201380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1061.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"15950_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13014-019-1256-6","volume":"14","author":"HK Byun","year":"2019","unstructured":"Byun HK, Kim N, Yoon HI, Kang SG, Kim SH, Cho J, et al. Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: Clinical usefulness of intensity modulated radiotherapy in the immuno-oncology era. Radiat Oncol. 2019;14(1):51. https:\/\/doi.org\/10.1186\/s13014-019-1256-6.","journal-title":"Radiat Oncol"},{"issue":"3","key":"15950_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/COC.0b013e3182940ff9","volume":"38","author":"AT Wild","year":"2015","unstructured":"Wild AT, Ye X, Ellsworth SG, et al. The association between chemoradiation-related lymphopenia and clinical outcomes in pancreatic adenocarcinoma. Am J Clin Oncol. 2015;38(3):259\u201365. (Context on lymphopenia across cancers).","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"15950_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1158\/2326-6066.CIR-13-0062","volume":"1","author":"JL Campian","year":"2013","unstructured":"Campian JL, Ye X, Brock M, Grossman SA. Treatment-related lymphopenia in patients with stage III non\u2013small-cell lung cancer. Cancer Immunol Res. 2013;1(5):313\u20138. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0062.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"15950_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/07357907.2012.762780","volume":"31","author":"S Yovino","year":"2013","unstructured":"Yovino S, Kleinberg L, Grossman SA, Narayanan M, Ford E. The etiology of treatment-related lymphopenia in patients with malignant gliomas: Modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest. 2013;31(2):140\u20134. https:\/\/doi.org\/10.3109\/07357907.2012.762780.","journal-title":"Cancer Invest"},{"issue":"2","key":"15950_CR28","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/j.ijrobp.2017.06.351","volume":"99","author":"JY Jin","year":"2017","unstructured":"Jin JY, Hu C, Xiao Y, Zhang H, Ellsworth S, Schild SE, et al. Higher radiation dose to immune system is correlated with poorer survival in patients with stage III non-small cell lung cancer: A secondary study of a phase 3 cooperative group trial (NRG Oncology RTOG 0617). Int J Radiat Oncol Biol Phys. 2017;99(2):S151.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"15950_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","volume":"101","author":"S Rudra","year":"2018","unstructured":"Rudra S, Hui C, Rao YJ, Samson P, Lin AJ, Chang X, et al. Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiotherapy for glioblastoma. Int J Radiat Oncol Biol Phys. 2018;101(1):217\u201325. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.069.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"15950_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ijrobp.2016.11.027","volume":"97","author":"LK Mell","year":"2017","unstructured":"Mell LK, Sir\u00e1k I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, et al. Bone marrow\u2013sparing intensity modulated radiation therapy: rationale and early clinical experience (example in cervical cancer). Int J Radiat Oncol Biol Phys. 2017;97(3):536\u201345. (Context on marrow sparing).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15950_CR31","doi-asserted-by":"publisher","unstructured":"KimN et al. Nomogram for radiation-induced lymphopenia in patients receiving IMRT-based chemoradiation for newly diagnosed glioblastoma: A multi-institutional study. lin Transl Radiat Oncol. 2024;47:100799. https:\/\/doi.org\/10.1016\/j.ctro.2024.100799.","DOI":"10.1016\/j.ctro.2024.100799"},{"issue":"7","key":"15950_CR32","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1172\/JCI34487","volume":"118","author":"C Sport\u00e8s","year":"2008","unstructured":"Sport\u00e8s C, Szabolcs P, Kohn DB, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by expanding naive CD4 T cells. J Clin Invest. 2008;118(7):2272\u20139. https:\/\/doi.org\/10.1172\/JCI34487.","journal-title":"J Clin Invest"},{"issue":"7","key":"15950_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","volume":"15","author":"M Lim","year":"2018","unstructured":"Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15(7):422\u201342. https:\/\/doi.org\/10.1038\/s41571-018-0003-5.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"15950_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","volume":"105","author":"CJ Ladbury","year":"2019","unstructured":"Ladbury CJ, Rusthoven CG, Camidge DR, Kavanagh BD, Nath SK. Impact of radiation dose to the host immune system on tumor control and survival for Stage III NSCLC treated with definitive RT. Int J Radiat Oncol Biol Phys. 2019;105(2):346\u201355. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.05.064.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15950_CR35","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJWL Aerts","year":"2014","unstructured":"Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006. https:\/\/doi.org\/10.1038\/ncomms5006.","journal-title":"Nat Commun"},{"issue":"3","key":"15950_CR36","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1148\/radiol.2016160845","volume":"280","author":"JE Park","year":"2016","unstructured":"Park JE, Kim HS, Moon SH, et al. Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models. Radiology. 2016;280(3):880\u20139. https:\/\/doi.org\/10.1148\/radiol.2016160845.","journal-title":"Radiology"},{"issue":"3","key":"15950_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1148\/radiol.2016161382","volume":"281","author":"P Kickingereder","year":"2016","unstructured":"Kickingereder P, Bonekamp D, Nowosielski M, Kratz A, Sill M, Burth S, et al. Radiogenomics of glioblastoma: machine learning-based classification of molecular characteristics by using multiparametric and multiregional MR imaging features. Radiology. 2016;281(3):907\u201318. https:\/\/doi.org\/10.1148\/radiol.2016161382.","journal-title":"Radiology"},{"issue":"2","key":"15950_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, van Griethuysen JJM. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-Based Phenotyping. Radiology. 2020;295(2):328\u201338. https:\/\/doi.org\/10.1148\/radiol.2020191145.","journal-title":"Radiology"},{"issue":"2","key":"15950_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2967\/jnumed.121.262464","volume":"63","author":"F Orlhac","year":"2022","unstructured":"Orlhac F, Eertink JJ, Cottereau AS, Zijlstra JM, Thieblemont C, Meignan M, Boellaard R, Buvat I. A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies. J Nucl Med. 2022;63(2):172\u20139. https:\/\/doi.org\/10.2967\/jnumed.121.262464. Epub 2021 Sep 16. PMID: 34531263; PMCID: PMC8805779.","journal-title":"J Nucl Med"},{"key":"15950_CR40","doi-asserted-by":"publisher","unstructured":"Oyibo P, Brynolfsson P, Spezi E. Integrating Radiomic Image Analysis in the Hero Imaging Platform. Proceedings of the Cardiff University School of Engineering Research Conference 2024, Cardiff, UK. 2024. https:\/\/doi.org\/10.18573\/conf3.g.","DOI":"10.18573\/conf3.g"},{"key":"15950_CR41","doi-asserted-by":"publisher","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162(1):55\u201363. doi: 10.7326\/M14-0697. Erratum in: Ann Intern Med. 2015;162(8):600. https:\/\/doi.org\/10.7326\/L15-0078-4. PMID: 25560714.","DOI":"10.7326\/L15-0078-4"},{"issue":"2","key":"15950_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41577-021-00568-1","volume":"22","author":"UM Cytlak","year":"2022","unstructured":"Cytlak UM, Dyer DP, Honeychurch J, et al. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nat Rev Immunol. 2022;22(2):124\u201338. https:\/\/doi.org\/10.1038\/s41577-021-00568-1.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"15950_CR43","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2)","volume":"24","author":"SC Formenti","year":"2018","unstructured":"Formenti SC, Rudqvist NP, Golden E, et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med. 2018;24(12):1845\u201351. https:\/\/doi.org\/10.1038\/s41591-018-0232-2).","journal-title":"Nat Med"},{"issue":"3","key":"15950_CR44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/neuonc\/noac239","volume":"25","author":"H Awada","year":"2023","unstructured":"Awada H, Paris F, Pecquesr C. Exploiting radiation immunostimulatory effects to improve glioblastoma outcome. Neuro Oncol. 2023;25(3):433\u201346. https:\/\/doi.org\/10.1093\/neuonc\/noac239.","journal-title":"Neuro Oncol"},{"issue":"6063","key":"15950_CR45","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1126\/science.1206936","volume":"334","author":"JI Alvarez","year":"2011","unstructured":"Alvarez JI, Dodelet-Devillers A, Kebir H, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science. 2011;334(6063):1727\u201331. https:\/\/doi.org\/10.1126\/science.1206936.","journal-title":"Science"},{"issue":"24","key":"15950_CR46","doi-asserted-by":"publisher","first-page":"13382","DOI":"10.3390\/ijms222413382","volume":"22","author":"VA Arrieta","year":"2021","unstructured":"Arrieta VA, Najem H, Petrosyan E, et al. The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia. Int J Mol Sci. 2021;22(24):13382. https:\/\/doi.org\/10.3390\/ijms222413382.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"15950_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","volume":"25","author":"TF Cloughesy","year":"2019","unstructured":"Cloughesy TF, Mochizuki AY, Orpilla JR, et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med. 2019;25(3):477\u201386. https:\/\/doi.org\/10.1038\/s41591-018-0337-7.","journal-title":"Nat Med"},{"key":"15950_CR48","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3389\/fimmu.2019.01767","volume":"10","author":"EK Holl","year":"2019","unstructured":"Holl EK, Frazier VN, Landa K, et al. Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer. Front Immunol. 2019;10:1767. https:\/\/doi.org\/10.3389\/fimmu.2019.01767.","journal-title":"Front Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15950-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15950-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15950-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:20:14Z","timestamp":1779207614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15950-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15950"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15950-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the present study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies using animals performed by any of the authors. This study has been approved by the Institutional Scientific Board of the IRCCS San Raffaele Scientific Institute (registration number CET 292-2024). All participants will sign an Informed Consent. Any protocol amendments will be communicated to ethics committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Miriam Torrisi received a speaker honorarium from Accuray Inc. independently from the current work. Laura Giannini received a research fellowship from AIRC: IG 25951 - project \u201cToward clinical use of PET in selecting patients with pancreatic cancer for local treatment intensification\u201d. Miriam Torrisi received a research grant from the Next Generation EU (PNRR-MCNT2-2023-12378239), with a project entitled \u201cRadio-immunotherapy in solid tumors\u201d (CUP Code: C43C24000320005). Andrei Fodor participated in a Johnson & Johnson Advisory Board not related to this paper.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"633"}}